Back to GetFilings.com



AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON NOVEMBER 13, 2003

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(MARK ONE)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2003

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

ACT OF 1934

FOR THE TRANSITION PERIOD FROM ___________________ TO _____________

COMMISSION FILE NUMBER 0-14669

THE ARISTOTLE CORPORATION

(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

DELAWARE

06-1165854

(STATE OR OTHER JURISDICTION OF

(I.R.S. EMPLOYER

INCORPORATION OR ORGANIZATION)

IDENTIFICATION NO.)

96 CUMMINGS POINT ROAD, STAMFORD, CONNECTICUT

(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)

06902

(ZIP CODE)

(203) 358-8000

(REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)

Indicate by check mark whether registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).

Yes [] No [X]

As of November 1, 2003, 17,047,254 shares of Common Stock, 1,053,522 shares of Series I Preferred Stock and 10,984,971 shares of Series J Preferred Stock were outstanding.

THE ARISTOTLE CORPORATION

INDEX OF INFORMATION CONTAINED IN FORM 10-Q FOR THE

QUARTER ENDED SEPTEMBER 30, 2003

 

PART I - FINANCIAL INFORMATION

 

Item 1.

Financial Statements

   

Condensed Consolidated Balance Sheets at September 30, 2003 (unaudited)

 
     

and December 31, 2002

1

   

Condensed Consolidated Statements of Earnings for the Three and Nine

 
     

Months ended September 30, 2003 and 2002 (unaudited)

2

   

Condensed Consolidated Statements of Cash Flows for the Nine Months

 
     

ended September 30, 2003 and 2002 (unaudited)

3

   

Notes to Condensed Consolidated Financial Statements (unaudited)

4

       
 

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of

 
     

Operations

10

       
 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

15

       
 

Item 4.

Controls and Procedures

16

       

PART II - OTHER INFORMATION

 

Item 6.

Exhibits and Reports on Form 8-K

17

 

PART I

ITEM 1. FINANCIAL INFORMATION

THE ARISTOTLE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)

 

Assets

September 30,

2003

December 31, 2002

(unaudited)

Current assets:

Cash and cash equivalents

$

7,058

11,299

Accounts receivable, net

22,109

12,452

Inventories

29,804

27,941

Prepaid expenses and other

5,777

7,766

Deferred income taxes

7,251

7,251

Total current assets

71,999

66,709

Property, plant and equipment, net

16,855

9,153

Goodwill

10,908

7,008

Deferred income taxes

16,743

21,761

Other assets

321

430

Total assets

$

116,826

105,061

Liabilities and Stockholders' Equity

Current liabilities:

Current installments of long-term debt

$

1,541

9,108

Trade accounts payable

8,889

5,522

Accrued expenses

4,148

3,979

Accrued dividends payable

-

2,150

Income taxes

680

1,005

Total current liabilities

15,258

21,764

Long-term debt, less current installments

41,356

27,579

Stockholders' equity:

Preferred stock, Series I, convertible, voting, 11% cumulative, $6.00 stated

value; $.01 par value; 2,400,000 shares authorized, 1,053,122 and 1,046,716

shares issued and outstanding at September 30, 2003 and December 31, 2002,

respectively

6,319

6,280

Preferred stock, Series J, non-voting, 12% cumulative, $6.00 stated value;

$.01 par value; 11,200,000 shares authorized, 10,984,971 shares

issued and outstanding

65,760

65,760

Common stock, $.01 par value; 20,000,000 shares authorized, 17,046,854 and

17,031,687 shares issued and outstanding at September 30, 2003 and December

31, 2002, respectively

170

170

Additional paid-in capital

668

251

Accumulated deficit

(12,569)

(16,624)

Accumulated other comprehensive loss

(136)

(119)

Total stockholders' equity

60,212

55,718

Total liabilities and stockholders' equity

$

116,826

105,061

The accompanying notes are an integral part of these condensed consolidated financial statements.

1

THE ARISTOTLE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS

(in thousands, except share and per share data)

(Unaudited)

Three Months Ended

Nine Months Ended

September 30,

September 30,

2003

2002

2003

2002

Net sales

$

51,953

55,485

130,355

133,337

Cost of sales

32,592

36,203

81,529

86,468

Gross profit

19,361

19,282

48,826

46,869

Selling and administrative expense

10,319

11,063

30,437

30,580

Earnings from operations

9,042

8,219

18,389

16,289

Other expense (income):

Interest expense

452

480

1,131

1,446

Other, net

(10)

(32)

(65)

(48)

442

448

1,066

1,398

Earnings before income taxes and extraordinary

gain

8,600

7,771

17,323

14,891

Income taxes:

Current

821

1,000

1,800

3,511

Deferred

2,572

2,015

5,018

2,345

3,393

3,015

6,818

5,856

Earnings before extraordinary gain

5,207

4,756

10,505

9,035

Extraordinary gain

-

-

-

20,237

Net earnings

5,207

4,756

10,505

29,272

Preferred dividends

2,150

2,191

6,450

2,498

Net earnings applicable to common shareholders

$

3,057

2,565

4,055

26,774

Basic earnings per common share:

Earnings before extraordinary gain, applicable to

common shareholders

$

.18

.15

.24

.41

Extraordinary gain

-

-

-

1.28

Net earnings applicable to common shareholders

$

.18

.15

24

1.69

Diluted earnings per common share:

Earnings before extraordinary gain, applicable to

common shareholders

$

.18

.15

.24

.41

Extraordinary gain

-

-

-

1.27

Net earnings applicable to common shareholders

$

.18

.15

.24

1.68

Weighted average common shares outstanding:

Basic

17,033,069

17,031,687

17,032,153

15,788,860

Diluted

17,206,851

17,139,708

17,164,339

15,915,255

The accompanying notes are an integral part of these condensed consolidated financial statements.

2

 

THE ARISTOTLE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

Nine Months Ended

September 30,

2003

2002

Cash flows from operating activities:

Net earnings

$

10,505

29,272

Adjustments to reconcile net earnings to net cash

provided by operating activities:

Extraordinary gain

-

(20,237)

Depreciation

1,336

1,238

Stock option compensation

397

136

Loss on sale of property, plant and equipment

17

11

Deferred income taxes

5,018

2,345

Change in assets and liabilities, net of effects of acquired business:

Accounts receivable

(9,211)

(9,873)

Inventories

(910)

(2,804)

Prepaid expenses and other

2,104

1,044

Other assets

109

11

Trade accounts payable

3,202

5,890

Accrued expenses and other liabilities

(457)

1,287

Net cash provided by operating activities

12,110

8,320

Cash flows from investing activities:

Purchases of property, plant and equipment

(3,516)

(1,117)

Proceeds from the sale of property, plant and equipment

7

-

Proceeds from the sale of marketable securities

-

284

Cash acquired in merger with Nasco

-

3,272

Cash paid for acquisitions, net of cash acquired

(3,449)

-

Net cash provided by (used in) investing activities

(6,958)

2,439

Cash flows from financing activities:

Proceeds from issuance of long-term debt

4,410

-

Principal payments on long-term debt

(5,262)

(4,417)

Proceeds from issuance of stock under stock option plans

59

-

Preferred dividends paid

(8,600)

(2,498)

Net cash used in financing activities

(9,393)

(6,915)

Net increase (decrease) in cash and cash equivalents

(4,241)

3,844

Cash and cash equivalents at beginning of period

11,299

4,465

Cash and cash equivalents at end of period

$

7,058

8,309

Supplemental cash flow information

Cash paid during the period for:

Interest

$

1,120

1,415

Income taxes

$

1,953

2,018

Non-cash investing and financing activities:

Notes payable and capital lease executed in connection with acquisitions

$

7,062

-

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

THE ARISTOTLE CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2003

(Unaudited)

 

  1. Nature of Operations and Basis of Presentation
  2. The Aristotle Corporation ("Aristotle") and its subsidiaries (together with Aristotle, the "Company"), founded in 1986, and headquartered in Stamford, CT, is a leading manufacturer and global distributor of educational, health, medical technology and agricultural products. A selection of over 80,000 items is offered, primarily through catalogs carrying the brand of Nasco (founded in 1941), as well as those bearing the brands of Simulaids, Triarco, Summit Learning, Hubbard Scientific, Scott Resources, Spectrum Educational Supplies, Haan Crafts and To-Sew. Products include educational materials and supplies for substantially all K-12 curricula, molded plastics, biological materials and items for the agricultural, senior care and food industries. Nasco, together with Simulaids, also offers simulation kits and manikins used for training in cardiopulmonary resuscitation and the fire and emergency rescue and patient care fields. The Company markets proprietar y product lines throughout all of its catalogs that provide exclusive distribution rights. The proprietary product lines are developed internally through the Company's research and development efforts and acquired externally through licensing rights from third parties.

    Prior to June 17, 2002, Aristotle was a holding company which, through its subsidiaries, Simulaids, Inc. ("Simulaids") and Safe Passage International, Inc. ("Safe Passage"), conducted business in two segments, the medical education and training products market and the computer-based training market. On June 17, 2002, Aristotle merged (the "Merger") with Nasco International, Inc. ("Nasco"), an indirect subsidiary of Geneve Corporation ("Geneve"), a privately-held diversified financial services company. Pursuant to the Merger, the separate corporate existence of Nasco ceased and Aristotle was the surviving entity. Immediately following the Merger, Aristotle's business was comprised of the operations of the Nasco group of companies, Simulaids and Safe Passage. Due to the relative sizes of the parties and conditions to the Merger, the transaction was accounted for as a reverse acquisition using the purchase method of accounting under accounting principles generally accepted in the United S tates of America. Accordingly, for accounting and reporting purposes, Nasco is deemed to be the acquiring company, and financial information reported for periods prior to the Merger is that of Nasco. In applying purchase accounting to the Merger, the assets and liabilities of Aristotle were adjusted to their fair market values at June 17, 2002. This included recognition of a significant deferred tax asset of approximately $30.7 million, which was principally attributable to Aristotle's Federal net operating tax loss carryforwards. As a result of such recognition, Aristotle's pre-merger goodwill and long-term assets of $8.3 million were reduced to zero and negative goodwill of $20.2 million was recognized as an extraordinary gain at the Merger date.

    On December 31, 2002, Aristotle sold its 80% ownership interest in Safe Passage in exchange for certain contingent payments. It is unlikely that contingent payments, if any, which are payable through 2008 and based upon the financial performance of Safe Passage, will be material to the financial statements.

    The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and notes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2003 are not necessarily indicative of results that may be expected for any other interim period or for the year ended December 31, 2003. For further information, refer to the consolidated financial statements and notes included in the Company's Proxy Statement-Prospectus dated May 15, 2002, Annual Report on Form 10-K for the year ended December 31, 2002 and Quarterly Reports on Form 10-Q for the quarters ended March 31, 2003 and June 30, 2003.< /P>

     

     

     

     

     

    4

    THE ARISTOTLE CORPORATION AND SUBSIDIARIES

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

    September 30, 2003

    (Unaudited)

  3. Business Combinations
  4. On May 31, 2003, Aristotle purchased 100% of the outstanding capital stock of Haan Crafts Corporation ("Haan"). Haan is a manufacturer and catalog distributor of sewing kits used in middle school and junior high school family and consumer science classrooms. The acquisition has complemented the Company's current product lines. The results of Haan's operations have been included in the consolidated financial statements since the date of such acquisition. The aggregate purchase price, net of cash acquired, was $5.3 million, including $3.5 million of cash and $1.8 million in seller financing. The purchase price allocation, which is subject to change, resulted in goodwill of $3.9 million attributable to the educational segment. In connection with the acquisition of Haan, Aristotle entered into a $1.2 million capital lease with the seller on a building facility. The Company intends to purchase the building facility between the date hereof and 2008.

    The following unaudited pro forma results of operations for three months ended September 30, 2002 and nine months ended September 30, 2003 and 2002 (in thousands) have been prepared as if the Haan acquisition had occurred on January 1, 2002:

    Three Months Ended

    Nine Months

    Ended

    September 30,

    September 30,

     

     

    2002

    2003

    2002

    Net sales

    $

    56,508

    133,201

    137,313

    Earnings before extraordinary gain

    4,813

    11,103

    9,486

    Net earnings

    $

    4,813

    11,103

    29,723

    Preferred dividends

    2,191

    6,450

    2,498

    Net earnings applicable to

    common shareholders

    $

    2,622

    4,653

    27,225

    Basic earnings per common share:

    Earnings before extraordinary gain,

    applicable to common shareholders

    $

    .15

    .27

    .44

    Extraordinary gain

    -

    -

    1.28

    Net earnings applicable to common

    shareholders

    $

    .15

    .27

    1.72

    Diluted earnings per common share:

    Earnings before extraordinary gain,

    applicable to common shareholders

    $

    .15

    .27

    .44

    Extraordinary gain

    -

    -

    1.27

    Net earnings applicable to common

    shareholders

    $

    .15

    .27

    1.71

     

    For the nine months ended September 30, 2003 and 2002, net earnings applicable to common shareholders on a pro forma basis would have increased $.03 per share (basic and diluted) had the Haan acquisition occurred on January 1, 2002.

    The pro forma financial information above is provided for comparative purposes only and should not be construed to be indicative of the Company's results of operations had the acquisition been consummated on January 1, 2002, and is not intended to project the Company's results of operations for any future period.

    5

    THE ARISTOTLE CORPORATION AND SUBSIDIARIES

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

    September 30, 2003

    (Unaudited)

    On May 31, 2003, Aristotle acquired 100% of the outstanding ownership interests in NHI, LLC ("NHI") from Nasco Holdings, Inc. ("Holdings"), a subsidiary of Geneve. This transaction was consummated in satisfaction of a contractual obligation entered into in connection with the Merger. The sole purpose of NHI is the ownership and management of a building facility, which had been leased to Aristotle. In connection with the purchase of NHI, Aristotle paid to Holdings an amount equal to the book value of NHI and assumed the $3.6 million mortgage related to the property held by NHI.

  5. Recently Issued Accounting Pronouncements
  6. In June 2001, the Financial Accounting Standards Board ("FASB") issued Statement of Financial Accounting Standards ("SFAS") No. 143, Accounting for Asset Retirement Obligations ("SFAS 143"). SFAS 143 requires the Company to record the fair value of an asset retirement obligation as a liability in the period in which it incurs a legal obligation associated with the retirement of tangible long-lived assets that result from the acquisition, construction, development and/or normal use of the assets. The Company also records a corresponding asset that is depreciated over the life of the asset. Subsequent to the initial measurement of the asset retirement obligation, the obligation will be adjusted at the end of each period to reflect the passage of time and changes in the estimated future cash flows underlying the obligation. The Company adopted SFAS 143 on January 1, 2003. The adoption of SFAS 143 did not have a material effect on the C ompany's financial statements for the three and nine months ended September 30, 2003.

    In June 2002, the FASB issued SFAS No.146, Accounting for Costs Associated with Exit or Disposal Activities ("SFAS 146"), which addresses financial accounting and reporting for costs associated with exit or disposal activities and supersedes Emerging Issues Task Force ("EITF") Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs Incurred in a Restructuring). SFAS 146 requires companies to recognize costs associated with exit or disposal activities when they are incurred rather than at the date of a commitment to an exit or disposal plan. In addition, SFAS 146 establishes that fair value is the objective for initial measurement of the liability. SFAS 146 is effective for exit or disposal activities initiated after December 31, 2002. The adoption of SFAS 146 did not have a material effect on the Company's financial statements for the three and nine months ended September 30, 2003.

    In November 2002, the EITF issued Issue No. 02-16, Accounting for Consideration Received from a Vendor by a Customer (Including a Reseller of the Vendor's Products) ("EITF 02-16"), effective for fiscal periods beginning after December 15, 2002. EITF 02-16 requires cash consideration received from a vendor be recognized in the customer's financial statements as a reduction to cost of goods sold, unless certain limited conditions are met. If these specific requirements related to individual vendors are met, the consideration is accounted for as a reduction in the related expense category, such as advertising or selling and administrative expense. The adoption of EITF 02-16 did not have a material effect on the Company's financial statements for the three and nine months ended September 30, 2003.

    In January 2003, the FASB issued Interpretation No. 46, Consolidation of Variable Interest Entities, an Interpretation of ARB No. 51 ("Interpretation 46"). Interpretation 46 addresses the consolidation by business enterprises of variable interest entities. Interpretation 46 applies immediately to variable interests in variable interest entities created after January 31, 2003, and to variable interests in variable interest entities obtained after January 31, 2003. Interpretation 46 requires certain disclosures in financial statements issued after January 31, 2003 if it is reasonably possible that the Company will consolidate or disclose information about variable interest entities when Interpretation 46 becomes effective. The adoption of Interpretation 46 did not have a material effect on the Company's financial statements for the three and nine months ended September 30, 2003.

    In April 2003, the FASB issued SFAS No. 149, Amendment of Statement 133 on Derivative Instruments and Hedging Activities ("SFAS 149"). SFAS 149 amends and clarifies financial accounting and reporting for derivative instruments, including certain derivative instruments embedded in other contracts and for hedging activities under SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities. SFAS No. 149 is effective for contracts entered into or modified after June 30, 2003 and for hedging relationships designated after June 30, 2003. The adoption of SFAS 149 did not have a material effect on the Company's financial statements for the three and nine months ended September 30, 2003.

    6

    THE ARISTOTLE CORPORATION AND SUBSIDIARIES

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

    September 30, 2003

    (Unaudited)

     

    In May 2003, the FASB issued SFAS No. 150, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity ("SFAS 150"). SFAS 150 establishes standards for how an issuer classifies and measures certain financial instruments with characteristics of both liabilities and equity. It requires an issuer to classify a financial instrument that is within its scope as a liability (or an asset in some circumstances). An issuer previously classified many of those instruments as equity. The Statement is effective for financial instruments entered into or modified after May 31, 2003, and otherwise is effective for interim periods beginning after June 15, 2003. The adoption of SFAS 150 did not have a material effect on the Company's financial statements for the three and nine months ended September 30, 2003.

  7. Stock Options
  8. The Company has one stock plan available to employees, directors and consultants and one plan available to employees and directors. In 2002, the Company adopted a change in accounting principle to adopt the fair value-based recognition and measurement provisions of SFAS No.123, Accounting for Stock-Based Compensation ("SFAS 123"), which requires the fair value of stock options granted to employees to be measured at the date of grant and recognized as an expense over the service period, which is usually the vesting period of the grant. Under SFAS 123, the Company recognizes the fair value of stock options granted on or after January 1, 2002 as an expense on its income statement over the vesting period of the grant. Previously, the Company accounted for fixed plan stock option grants using the intrinsic value-based method and recognized expense only when the grant date fair value of the underlying stock exceeded the exercise price under the award. No stock options were issued during the three months ended September 30, 2003. The total fair value of the options issued during the nine months ended September 30, 2003 was $.4 million. The total fair value of options granted under the 2002 Employee, Director and Consultant Stock Plan is recognized as non-cash compensation expense over the three year vesting period for such options. The Company recorded compensation expense related to issued stock options of approximately $.1 million for the three months ended September 30, 2003 and 2002. The Company recorded compensation expense related to issued stock options of approximately $.4 million for the nine months ended September 30, 2003, an increase of $.3 million from the $.1 million recorded for the nine months ended September 30, 2002. The expected annual impact on earnings before income taxes of the options granted to date is a reduction of approximately $.5 million.

  9. Comprehensive Earnings
  10. Comprehensive earnings for the three and nine months ended September 30 is as follows (in thousands):

    Three Months Ended

    Nine Months Ended

    September 30,

    September 30,

     

     

    2003

    2002

    2003

    2002

    Net earnings

    $

    5,207

    4,756

    10,505

    29,272

    Foreign currency translation

    adjustment

    95

    (28)

    (17)

    (23)

    Net unrealized investment gain

     

    -

    1

    -

    15

    Comprehensive earnings

    $

    5,302

    4,729

    10,488

    29,264

     

     

     

    7

    THE ARISTOTLE CORPORATION AND SUBSIDIARIES

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

    September 30, 2003

    (Unaudited)

  11. Earnings per Common Share
  12. Basic earnings per common share is calculated by dividing net earnings applicable to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings per common share is calculated by dividing net earnings applicable to common shareholders by the weighted average number of common shares outstanding during the period and including each share that would have been outstanding assuming the issuance of common shares for all dilutive potential common shares outstanding during the period.

    Shares of Common Stock available for issue upon conversion of the 1,053,122 and 1,046,716 shares of Series I Preferred Stock outstanding at September 30, 2003 and 2002, respectively, were not dilutive and, therefore, have not been included in the computations of diluted earnings per common share amounts for the periods then ended.

  13. Segment Reporting
  14. The Company's business activities are organized into two business segments, educational and commercial. The educational segment relates to instructional teaching aids and materials, which are distributed to educational institutions principally in North America, for kindergarten through grade 12 classes, and for nursing school and emergency medical instructors. Products in the educational segment are marketed primarily through catalogs. The growth potential of the educational segment is directly related to school enrollments and the strength of government funding of education. The commercial segment relates to agricultural products, sterile sampling containers and systems, materials for nursing home activities and novelty and gift products. Products in the commercial segment are marketed through catalogs nationwide and through a worldwide dealer network covering more than 60 countries. Market growth in the commercial segment is principally impacted by the general e conomic conditions of world agriculture, the increasing size of the aged population, as well as increasing global awareness of food and water quality standards. The Company evaluates the performance of these segments based on segment net sales and gross profit.

    The following table presents segment information for the three and nine months ended September 30 (in thousands):

    Three Months Ended

    Nine Months Ended

    September 30,

    September 30,

     

     

    2003

    2002

    2003

    2002

    Net sales: